Marketplace math validated, shifting focus to Medicaid risk
- Centene is the largest Medicaid managed care provider, with about 13 million Medicaid members.
- Management raised 2026 adjusted EPS guidance to greater than $4.80 after strong Q2 results.
- The June Wakely report validated Centene's Marketplace strategy, pushing expected pretax margins to 4.5 to 5 percent.
- Medicaid membership attrition is expected to reach 8 to 9 percent as states prepare for OB3 regulations.
- Medicare Part D is performing ahead of expectations, with pretax margins expected to exceed 3 percent.
Bull case validated by risk adjustment win
Centene spent the first half of 2026 proving that its pricing strategy worked. The release of the June Wakely data confirmed that the company successfully attracted a higher-acuity Marketplace population that generated a large risk adjustment receivable. This allowed management to raise full-year 2026 adjusted EPS guidance to greater than $4.80.
The bull case is now firmly in execution mode. The company expects a 4.5 to 5 percent pretax margin in its Marketplace business, up from earlier conservative estimates. Medicare Part D is also performing better than expected, providing a second tailwind for the year.
The bear case has shifted from Marketplace risk to Medicaid execution. Bears are focused on the impact of upcoming OB3 legislation, which could drive Medicaid membership down 8 to 9 percent. If states do not adequately adjust 2027 Medicaid rates to account for the resulting acuity shift, the core business could face renewed margin pressure.
This is a recovery story that just cleared a major hurdle. The company has scale and a clear earnings path for 2026, but the regulatory environment heading into 2027 keeps the longer-term outlook complex.
Paid per member, hurt by claims
Centene is a managed care organization. Governments and members pay it premiums, often on a per-member-per-month basis. Centene then pays doctors, hospitals, pharmacies, and other providers for care.
The business works when premiums are set higher than medical costs and overhead. A key metric is the health benefits ratio, or HBR, which means medical costs as a percent of premium revenue. Lower is usually better, as long as care quality holds up.
Centene's edge comes from scale in Medicaid, long ties with state governments, and experience serving lower-income and complex-needs members. That also creates risk. States set many rates, rules can change, and sick members can quickly raise claims costs.
Technology and tighter operations can help. Management has pointed to data, clinical programs, network design, and fraud prevention as tools to lower cost. Still, pricing and regulation matter more here than brand power.
Four big health-plan engines
Medicaid
This is Centene's largest business line. It serves low-income families and higher-need members, and the main test is whether state rates keep up with medical cost trend.
Ambetter Marketplace
Ambetter sells ACA plans to individuals. It is the main recovery lever, now expecting a 4.5 to 5 percent pretax margin based on strong risk adjustment.
Medicare Advantage
Centene is managing this business for profit, not just size. Management is aiming for Medicare Advantage breakeven by 2027.
Medicare Part D
Part D covers prescription drugs for seniors. The segment is outperforming expectations with a projected pretax margin greater than 3 percent.
Dual-eligible plans
These serve people who qualify for both Medicare and Medicaid. Centene may benefit over time because future CMS rules push more integrated care through D-SNP plans.
Other services
This bucket includes pharmacy operations, vision and dental, clinical care, behavioral health, and corporate services.
Medicaid still sets the tone
Mix is based on Q1 2026 total external revenues from the Form 10-Q. Medicaid is the largest segment, so state rates and medical cost trend have an outsized effect on the company.
What could break the recovery
Medicaid cost trend outruns rates
High impact · Medium oddsMedicaid is Centene's biggest business. Membership attrition is expected to reach 8 to 9 percent as states prepare for new OB3 regulations. If state rate increases lag the new cost level and shifting acuity pool, margins can slip.
Regulation cuts members and worsens mix
High impact · High oddsThe OBBBA, the Marketplace Integrity and Affordability Final Rule, and the end of enhanced APTCs are expected to reduce 2026 Marketplace membership. These regulatory changes could also continue to increase the overall morbidity of the Marketplace population.
Medicare execution stays uneven
Medium impact · Medium oddsMedicare Advantage is still on a path toward breakeven by 2027, not already fixed. Part D is performing well, but a delay in CMS payments tied to Part D receivables could pressure cash flow.
Debt limits capital returns
Medium impact · Medium oddsCentene relies on its balance sheet to meet regulated capital rules. Buybacks could stay paused if management favors debt paydown or needs to support organic capital requirements.
In one breath
How does Centene make money?
Centene collects premiums for health-plan members, often from state and federal programs. It makes money when medical claims and operating costs come in below those premiums.
Why is Marketplace risk adjustment so important for Centene?
Risk adjustment moves money toward plans that cover sicker ACA members. Centene attracted a higher-acuity Silver population, which generated a substantial risk adjustment receivable confirmed by mid-year data.
Is Medicaid good or bad for Centene?
Medicaid is Centene's core strength and its biggest exposure. Scale helps, but profits depend on states setting rates that match the real cost of care.
Why did Centene raise 2026 guidance?
Management raised adjusted EPS guidance to greater than $4.80 after strong Q2 results. The raise was driven by a favorable Wakely report on Marketplace risk adjustment and strong Medicare Part D performance.
